The Clinical Value of Dual Time Point F-18 FDG PET/CT Imaging for the Differentiation of Colonic Focal Uptake Lesions |
Kim, Jin-Suk
(Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Lim, Seok-Tae (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital) Jeong, Young-Jin (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital) Kim, Dong-Wook (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital) Jeong, Hwan-Jeong (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital) Sohn, Myung-Hee (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital) |
1 | Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radioreaphics 2007;27:145-59 DOI ScienceOn |
2 | Israel O, Yefremov N, Bar-Shalom R, Kaqana O, Frenkel A. PET/CT detection of unexpected gastrointestinal foci of F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005;46:758-62 PUBMED ScienceOn |
3 | Nishiyama Y, Yamamoto Y, Monden T, Sasakawa Y, Tsutsui K, Wakabayashi H, et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nucl Med Commun 2005;26:895-901 DOI ScienceOn |
4 | Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Posit Imaging 1999;2:273-80 DOI ScienceOn |
5 | Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Nagai A, Ohnuki T, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 2006;47:426-31 PUBMED ScienceOn |
6 | Lan XL, Zhang YX, Wu ZJ, Jia Q, Wei H. The value of dual time point F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 2008;63:756-64 DOI ScienceOn |
7 | Thie JA. Optimizing dual-time and serial positron emission tomography and single photon emission computed tomography scans for diagnoses and therapy monitoring. Mol Imaging Biol 2007;9:348-56 DOI ScienceOn |
8 | Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74 DOI ScienceOn |
9 | Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002;224:783-7 DOI ScienceOn |
10 | Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed F -fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000;89:2547-54 DOI ScienceOn |
11 | Nishivama Y, Yamamoto Y, Fukunaqa K, Kimura N, Miki A, Sasakawa Y. Dual-time-point F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med 2006;47:633-8 PUBMED ScienceOn |
12 | Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AT. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994;35:1308-12 PUBMED ScienceOn |
13 | Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point F -FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43:871-5 PUBMED ScienceOn |
14 | Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual time-point imaging to improve breast cancer diagnosis with F -FDG PET. J Nucl Med 2005;46:1819-24 ScienceOn |
15 | Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentineinduced inflammatory tissue. J Nucl Med 1995;36:1301-6 PUBMED ScienceOn |
16 | Liang Y-C, Tang A-W, Xu H. Diagnostic value of F-FDG PET delayed imaging for patients with primary lung cancer. Chin J Nucl Med 2004;24:27-9 |
17 | Hubner KF, Buonocore E, Gould HR, Thie J, Smith GT, Stephens S, et al. Differentiating benign from malignant lung lesions using “quantitative” parameters of FDG PETimages. Chin J Nucl Med 1996;21:941-9 PUBMED |
18 | Rohren EM, Turking TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305-32 DOI ScienceOn |
19 | Zhuang H, Pourdehnad M, Lambright ES, Yammoto AJ, Lanuti M, Mozley PD, et al. Dual time point F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7 PUBMED ScienceOn |
20 | Lodge MA, Lucas JD, Marsden PK, Cronin BF, O'Doherty MJ, Smith MA. A PET study F-FDG uptake in soft tissue masses. Eur J Nucl Med 1999;26:22-30 DOI ScienceOn |
21 | Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. -FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 2003;44:540-8 PUBMED ScienceOn |
22 | Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77 DOI PUBMED ScienceOn |
23 | Jarritt PH, Carson KJ, Hounsell AR, Visvikis D. The role of PET/CT scanning in radiotherapy planning. Br J Radiol 2006;79:S27-35 DOI ScienceOn |